Global B2B Pharmaceutical Sourcing · Dossier Licensing · Named-Patient Access
💬 WhatsApp · Sign in · Register

CDMO and Contract Pharma Manufacturing: Guide Hub for Buyers (2026)

Mitul Agarwal
Written by Mitul Agarwal · B.Pharm, MBA
Founder & Head of Business Development · 25+ years in international pharmaceutical BD&L
Published 2 October 2026
CDMO and Contract Pharma Manufacturing: Guide Hub for Buyers (2026)

By Mitul Agarwal, B.Pharm, MBA. Published 2 October 2026.

Short answer: a CDMO (contract development and manufacturing organisation) develops and makes medicines for another company, from formulation work through to commercial batches. A CMO only manufactures to an existing process. This page brings together all of PharmaTradz's guides on choosing, verifying and working with contract manufacturers, so you can go straight to the one that answers your question.

The words people mix up

  • CMO (contract manufacturing organisation): makes your product using a process and specifications you already have.
  • CDMO: also develops it: formulation, scale-up, stability studies and the technical documents for registration.
  • White label or private label: you sell the manufacturer's existing, registered product under your own brand. It's usually the fastest route, because development is already done.
  • Loan licence (India) or toll manufacturing: you hold the product licence and the plant manufactures on your behalf.
  • Tech transfer: moving a proven process from one site to another, often to a plant in the destination country to meet local-manufacturing rules.

Find the right guide

Your questionRead this
Which CDMOs are the big global names, and how do I choose one?Top global CDMO companies in 2026: a buyer's guide
Which Indian CDMOs should I shortlist?50+ leading CDMO companies in India
I need a contract manufacturer for an off-patent generic.Best CDMOs for generic and off-patent drugs
I need an API made to order.Top CDMOs for small-molecule APIs in 2026
I need injectables: vials, lyophilised products or prefilled syringes.Injectable and sterile CDMOs: what to verify before an RFQ
I need biologics or cell therapy capacity in Europe.15+ European contract manufacturers for biologics and cell therapies
I need biosimilar or advanced-therapy capacity in Latin America.Contract manufacturers in Brazil for biosimilars and Latin American partners for advanced therapies
I only need packing and labelling for my market.Contract packaging and labelling partners: cost, MOQ and regulatory fit
I want my own brand of nutraceuticals made for me.Private-label nutraceutical manufacturing (OEM/ODM)
Should we outsource or build our own plant?Contract manufacturing vs building in-house
Why do so many buyers outsource to India?Why global pharma companies prefer India for CDMO services
How do Indian plants meet US FDA, EU and WHO GMP?How Indian CDMOs comply with US FDA, EU GMP and WHO GMP
I have a dossier, not a plant. Can I license it out?Out-licensing a generic dossier: what buyers check and how deals are priced

Sourcing from India, by region and country

Most of our buyers outsource to India. These guides explain the route from India to their market:

Country pages: Brazil, Mexico, Argentina, Chile, Colombia, Venezuela, Saudi Arabia, UAE, Egypt, South Africa, Nigeria, Kenya, Ghana, Indonesia, Philippines, Singapore, Thailand, Myanmar, Germany, United States, Russia.

Registration comes before manufacturing in most markets. Our import guides hub compares the fast-track routes for products approved abroad in 45 countries, and many governments now favour local manufacturing, which is where tech transfer and licensing come in.

Before you sign with any manufacturer

  1. Check the certificates yourself. Look up the site's GMP status with the issuing regulator, not just a PDF from the supplier. See how to verify a pharmaceutical supplier and which certifications actually matter.
  2. Match the approvals to your market. A WHO-GMP site may be fine for many emerging markets but not for the EU or US. The plant's inspection history matters more than its brochure.
  3. Ask what documents you will own. Who holds the dossier, the stability data and the API documents? Our guides to CTD vs ACTD and CEP, DMF and ASMF explain what to ask for.
  4. Put quality in writing. A quality agreement should say who releases batches, who handles complaints and recalls, and how changes are notified.
  5. Write a clear RFQ. Product, strength, pack, annual volume, destination and documents needed. Our RFQ checklist and template shows how.

How PharmaTradz can help

Tell us what you need made, and where it will be sold: send an RFQ. We usually reply within 48 hours with matched manufacturers and their document status.


Frequently Asked Questions(FAQs)

What is the difference between a CMO and a CDMO?

A CMO manufactures to your existing process. A CDMO also develops the product: formulation, scale-up, stability and registration documents.

Is white labelling the same as contract manufacturing?

Not quite. With white labelling you sell a product the manufacturer has already developed and registered, under your brand. With contract manufacturing the product is made to your specification, and you usually own the dossier.

How do I check that a manufacturer is really WHO-GMP certified?

Ask for the certificate, then confirm it with the authority that issued it, and ask for the latest inspection outcome. Our WHO-GMP verification guide walks through it.

Can a CDMO help me meet local-manufacturing rules?

Yes. Many markets now favour locally made products, so CDMOs increasingly offer tech transfer to a plant in your country, or supply bulk for local filling and packing.

Disclaimer: The information presented in this article is for informational and educational purposes only. While every effort has been made to ensure data accuracy and reliability, readers are advised to independently verify all figures, regulations, and market insights before making any business or investment decisions.

Category: Pharma Blogs

← Back to All Articles

 

Subscribe to Our Newsletter

Stay updated on pharma trends and sourcing opportunities.

Please enter the correct answer.
This website uses cookies to ensure you get the best experience. By using our site, you agree to our Privacy Policy.
WhatsApp us